Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
9,064 | Dovepress* | 7,829+ | 1,123 | 8,952 | |
PubMed Central* | 1,235 | 289 | 1,524 | ||
Totals | 9,064 | 1,412 | 10,476 | ||
*Since 1 November 2018 |
View citations on PubMed and Google Scholar